Sboll is Your Go-to Source for the Latest Finance News, Covering Markets, Banking, Investments, Economy and Stocks.
⎯ 《 Sboll • Com 》
Global investors relieved by China tech rebound, but not convinced yet
Global investors relieved by China tech rebound, but not convinced yet
By Xie Yu and Summer Zhen HONG KONG (Reuters) -Rather than spur a relief rally in China's battered tech sector,
2023-07-13 07:28
Top Chinese Smartphone Maker Exits Chip Design as Sector Reels
Top Chinese Smartphone Maker Exits Chip Design as Sector Reels
Oppo, China’s biggest domestic smartphone maker, is closing its chip design business as the global smartphone market extends
2023-05-12 12:57
John D. Carpten, Ph.D., City of Hope’s Chief Scientific Officer, Elected to Prestigious National Academy of Medicine
John D. Carpten, Ph.D., City of Hope’s Chief Scientific Officer, Elected to Prestigious National Academy of Medicine
LOS ANGELES--(BUSINESS WIRE)--Oct 9, 2023--
2023-10-09 22:27
Billionaire Branson Won’t Put More Money in Virgin Galactic
Billionaire Branson Won’t Put More Money in Virgin Galactic
Richard Branson doesn’t plan further investments in Virgin Galactic Holdings Inc., the unprofitable space tourism venture he founded,
2023-12-02 21:59
Factbox-Consolidation in US health insurance industry
Factbox-Consolidation in US health insurance industry
By Deena Beasley Health insurer Cigna is in merger talks with Humana, a source familiar with the matter
2023-11-30 08:48
Cruise testing continues in Japan, Dubai, even as vehicles parked in US
Cruise testing continues in Japan, Dubai, even as vehicles parked in US
By Greg Bensinger SAN FRANCISCO Days after General Motors’ Cruise self-driving car unit pulled all of its vehicles
2023-11-18 06:46
One year on, Nord Stream sabotage remains a mystery
One year on, Nord Stream sabotage remains a mystery
The September 26, 2022 explosions that damaged the Nord Stream pipelines cut off a major route for Russian gas exports to Europe and fuelled geopolitical tensions already running...
2023-09-23 13:46
Anthos Therapeutics' Novel Dual-Acting Factor XI/XIa Inhibitor, Abelacimab 150 mg, Demonstrated a 67% Reduction in the Primary Endpoint of Major or Clinically Relevant Non-Major Bleeding Compared with Rivaroxaban in Patients with Atrial Fibrillation
Anthos Therapeutics' Novel Dual-Acting Factor XI/XIa Inhibitor, Abelacimab 150 mg, Demonstrated a 67% Reduction in the Primary Endpoint of Major or Clinically Relevant Non-Major Bleeding Compared with Rivaroxaban in Patients with Atrial Fibrillation
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 12, 2023--
2023-11-12 21:55
Port workers join Tesla strike in Sweden
Port workers join Tesla strike in Sweden
Workers at four Swedish ports blocked the loading and unloading of Tesla cars Tuesday in a growing strike movement over the US company's refusal to sign...
2023-11-07 20:20
Blackstone's quarterly earnings slump 39% as asset sales plummet
Blackstone's quarterly earnings slump 39% as asset sales plummet
By Chibuike Oguh NEW YORK Blackstone Inc said on Thursday its second-quarter distributable earnings slumped nearly 40%, owing
2023-07-20 19:25
More Migrants In Big US Cities Bring New Tensions for Democrats
More Migrants In Big US Cities Bring New Tensions for Democrats
In August 2022, after greeting one of the first buses of immigrants arriving in New York City with
2023-09-08 18:48
Dam Destroyed in the Dead of Night Upstages Ukraine’s Counteroffensive
Dam Destroyed in the Dead of Night Upstages Ukraine’s Counteroffensive
The 24 hours before Tuesday’s flooding of the Dnipro River basin were already dramatic, as Ukraine appeared on
2023-06-07 17:23